Beyond use dates are used for compounded preparations and are generally in days or months.
The major problem for pharmacists is that the stability of compounded formulations often is not known.
Such confusion is considered to have a negative effect on therapeutic adherence and therefore considered as a risk to public and/or animal health.
Acceptance of such different tablet appearances in the specification of a single strengthproduct would formally also allow the company to dispense these two appearances in the same container/blister, which may even cause greater confusion.
Also, If the compounded formulation is an official monograph in the USP/NF, the beyond use date given in the monograph can be used provided the procedure in the monograph was followed.
When an official monograph isn't present, a systematic approach to assigning the date can be as follows: Step 1.
Variolae vaccinae...known...[as]..Cow Pox, in which he described the protective effect of cowpox against smallpox.
He used it in 1798 in the long title of his Inquiry into the...
widespread immunity due to vaccination is largely responsible for the worldwide eradication of smallpox and the restriction of diseases such as polio, measles, and tetanus from much of the world.
The World Health Organization (WHO) reports that licensed vaccines are currently available to prevent or contribute to the prevention and control of twenty-five infections.
Ergogenic uses for AAS in sports, racing, and bodybuilding as performance-enhancing drugs are controversial because of their adverse effects and the potential to gain unfair advantage in competitive physical competitions.
Their use is referred to as doping and banned by most major sporting bodies.